PLOS Medicine publishes research and commentary of general interest with clear implications for patient care, public policy or clinical research agendas.
Contributed equally to this work with:
Department of Neurobiology, The Weizmann Institute of Science, Rehovot, Israel
Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel
Neuroimmunology Unit, DIBIT and Institute of Experimental Neurology (INSPE), San Raffaele Scientific Institute, Milan, Italy
Department of Internal Medicine, University of Regensburg, Regensburg, Germany
* E-mail: email@example.com (SJ); firstname.lastname@example.org (MS)
This question is to determine if you're a human visitor in order to prevent automated spam
Your submission will be reviewed by our staff.
There was a problem with your submission. Please try again later.